ACT With Chloroquine, Amodiaquine & Sulphadoxine-pyrimethamine in Pakistan
Studies on Adding Artesunate to Existing Antimalarial Therapies With Chloroquine, Amodiaquine & Sulphadoxine-pyrimethamine in Pakistan
Sponsor: HealthNet TPO
A PHASE3 clinical study on Falciparum Malaria and Malaria, this trial is completed. The trial is conducted by HealthNet TPO and has accumulated 7 data snapshots since 2001. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Apr 2019 — Jan 2021 [monthly]
Completed PHASE3
-
Jun 2018 — Apr 2019 [monthly]
Completed PHASE3
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE3
First recorded
Jun 2001
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- HealthNet TPO
- London School of Hygiene and Tropical Medicine
- Malaria Control Program, Directorate of Malaria Control, Pakistan
- United Nations High Commissioner for Refugees
- World Health Organization
For direct contact, visit the study record on ClinicalTrials.gov .